Untitled

HealthTrust presents…“Beyfortus: A Shot at Protection Against Respiratory Syncytial Virus (RSV) for Infants & Neonates”

Respiratory Syncytial Virus (RSV) is a common and highly contagious respiratory virus that is currently the leading cause of hospitalization in infants under 12 months of age due to lower respiratory tract infections and serious lung conditions. Prevention options have been historically limited, but the introduction of Beyfortus (nirsevimab), a monoclonal antibody injection, provides a new opportunity for season long passive immunity. Understanding the evidence of efficacy and safety in preventing hospitalization, intubation, and/or steroid use in neonates and infants is essential for optimizing pediatric care during RSV season.

Learning Objectives | At the end of this session, participants should be able to:

1. Recall the mechanism of action and role of nirsevimab (Beyfortus) in
   preventing respiratory syncytial virus (RSV) in infants.
2.  Identify current evidence-based recommendations from the Centers for
   Disease Control and Prevention (CDC) and the American Academy of
   Pedictrics (AAP) regarding eligibility and timing for nirsevimab (Beyfortus)
   administration.
3. Recognize the key clinical evidence and best practices supporting the safety
   and efficacy of nirsevimab (Beyfortus) in the infant population.

Presenter:

Somer Pye, PharmD  |  PGY1 Pharmacy Resident  |  McLeod Health  |  Florence, SC

Target Audience:  Pharmacists & Nurses

CE Credit: Approved for Pharmacists & Nurses

This program is pending approval for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy & Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is pending. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

By attending this program offered by Healhtrust, participants may earn up to 1  ACHE Qualified Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.

Belmont University CPHS Policy on Privacy & Confidentiality: 

• All registration information for CPE activities collected in the registration system and/or on paper (e.g., sign-in sheet) is kept confidential and used only for the purpose of awarding CPE credit.
• Archived recordings of CPE activities are edited so that only the presenter’s shared screen and image are visible. Comments entered into a chat box during the CPE activity will be excluded from the recording whenever possible.
• CPHS does not share with any third party (including ineligible companies) or its agents the names or contact information of CPE learners without the explicit consent of the individual learner. If a third-party requests that information be shared with CPHS CPE participants, CPHS will receive the requested information from the third party and share it with CPE participants via CPHS’s own communication methods.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.